Condition
Axial Spondyloarthritis clinical trials and research
As of November 12, 2026, Find a Trial lists 17 Axial Spondyloarthritis clinical trials that are recruiting, at sites in 16 countries (most in Germany (4), United States (4), China (3)). By phase: Phase 4 (3), Phase 2 (2), Phase 1 (2), Phase 2/3 (1). There are also 4 NIH-funded research projects on Axial Spondyloarthritis, with $856,258 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 17Clinical trials
- 4NIH research projects
- 16Countries
Newest Axial Spondyloarthritis clinical trials
All recruiting trials (17)
-
Surface topography and spine damage in radiographic axial spondyloarthritis
This study tests whether a radiation-free 3D surface topography method can reflect spine damage and sagittal balance in adults with radiographic axial spondyloarthritis.
-
RENEW: a digital program to help people with axial spondyloarthritis manage energy and symptoms
A web-based, peer-led program called RENEW is tested to see if people with axial spondyloarthritis can easily use it, like it, and benefit from it in managing fatigue and symptoms.
-
ExerciseRx app for people with axial spondyloarthritis
A mobile app called ExerciseRx is tested to see if it helps people with axial spondyloarthritis exercise more regularly and feel better than usual care.
-
Carotid ultrasound to guide prevention of heart disease in inflammatory rheumatic diseases
In people with inflammatory rheumatic diseases like RA, PsA, AxSpA, or SLE who are at modest cardiovascular risk, a carotid ultrasound test is used to see if they should start stronger lipid-lowering therapy to prevent heart problems.
-
Bimekizumab by IV infusion versus subcutaneous injection for adults with psoriatic arthritis or axial spondyloarthritis
This trial tests whether bimekizumab given by intravenous (IV) infusion behaves the same in the body as the usual subcutaneous injection in adults with psoriatic arthritis or axial spondyloarthritis.
-
Butantan live tetravalent dengue vaccine for people with autoimmune rheumatic diseases
This study will test whether a single dose of the Butantan live tetravalent dengue vaccine is safe and produces immune responses in clinically stable people aged 12–59 with autoimmune rheumatic diseases compared with matched healthy volunteers.
-
Assessing Bimekizumab Levels in Breast Milk of Nursing Mothers
This study tests how much of the medication bimekizumab is found in the breast milk of mothers who have been using it for at least 12 weeks after giving birth to see if it's safe for their babies.
-
Observing the progression of axial spondyloarthritis in Chinese patients
This study looks at how axial spondyloarthritis changes over time in Chinese adults to better understand the disease and its effects.
-
Evaluating movement recommendations for patients with axial spondyloarthritis using smartwatches
This study is testing how using smartwatches to track movement can help people with axial spondyloarthritis find better ways to stay active and manage their symptoms.
-
Investigating the causes and progression of axial spondylitis
This study is trying to understand how axial spondylitis starts and progresses in newly diagnosed patients to help improve treatments and find better ways to prevent the disease.
-
Fecal microbiota transplantation for treating axial spondyloarthritis
This study is testing if a treatment using gut bacteria from healthy donors can help people with axial spondyloarthritis who aren't feeling better with their current medications.
-
Evaluating the effects of 608 in patients with non-radiographic axial spondyloarthritis
This study is testing a new treatment called 608 to see if it can help adults with non-radiographic axial spondyloarthritis feel better compared to a placebo.
-
Evaluating tofacitinib for early active axial spondyloarthritis
This study is testing if a medication called tofacitinib can help people with early active axial spondyloarthritis who haven't found relief from traditional pain relievers.
-
High-intensity training for patients with spondyloarthritis
This study tests if high-intensity interval training can help people with spondyloarthritis feel better and stick to their exercise routines compared to regular training.
-
Observational study on newly diagnosed axial spondyloarthritis in the UK
This study looks at how being diagnosed later with axial spondyloarthritis affects work and daily life for people in the UK who have just been diagnosed and haven’t started biologic treatment yet.
-
Fecal microbiota transplantation for patients with axial spondyloarthritis not responding to standard treatments
This study is testing if a treatment using fecal microbiota transplantation can help people with axial spondyloarthritis who haven't found relief from standard medications.
-
Investigating the effects of stopping anti-inflammatory drugs in patients with axial spondyloarthritis
This study is testing whether stopping anti-inflammatory drugs helps people with axial spondyloarthritis who are in remission stay that way without having flare-ups.
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Understanding early triggers of axial spondyloarthritis in people at risk
This grant aims to understand the early immune changes that lead to axial spondyloarthritis in people who carry a genetic risk, with new peptide tools to distinguish harmful from protective T cells.
-
Pathogenic T cells in axial spondyloarthritis and eye inflammation
Researchers are studying eye-specific and shared immune mechanisms in axial spondyloarthritis to understand how T cells contribute to eye inflammation and related joint disease, with findings that could guide future treatments.
-
Identifying harmful immune cells in axial spondyloarthritis
This study is looking at how certain immune cells affect eye inflammation in people with axial spondyloarthritis, which could help us understand how this condition impacts both the eyes and joints.
-
Identifying harmful T cells in a type of arthritis that affects the spine and eyes
This study is looking at how certain immune cells, called CD8 T cells, behave in people with axial spondyloarthritis, especially when it causes eye inflammation, to help us understand the condition better and find new ways to treat it.
Related topics
Quick answers
How many Axial Spondyloarthritis clinical trials are recruiting right now?
17, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 16 countries. The most sites are in Germany (4 trials), United States (4 trials), China (3 trials), Spain (2 trials), Sweden (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 3, Phase 2: 2, Phase 1: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.